<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001143313</cik>
        <entityName>NYSE AMERICAN LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001739174</cik>
        <entityName>BiomX Inc.</entityName>
        <fileNumber>001-38762</fileNumber>
        <address>
            <street1>17 State Street 21st Floor</street1>
            <city>New York</city>
            <stateOrCountryCode>NY</stateOrCountryCode>
            <stateOrCountry>NEW YORK</stateOrCountry>
            <zipCode>10004</zipCode>
        </address>
        <telephoneNumber></telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Nicolas Connolly</signatureName>
        <signatureTitle>Analyst, Regulation</signatureTitle>
        <signatureDate>2024-10-25</signatureDate>
    </signatureData>
</notificationOfRemoval>
